Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Nutr ; 103(3): 309-13, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19728894

RESUMO

Most of the investigations for an alternative medicinal treatment on atherosclerosis have been focused on natural or dietary compounds including phytochemicals. So far, few studies regarding anti-atherosclerotic small peptides except for tetrapeptide of Lys-Arg-Glu-Ser have been reported. The present study was, thus, to investigate whether dipeptide Trp-His, which is one of vasodilating small peptides, could reduce atherosclerotic lesions in apo E-deficient mice fed a high-fat diet. The animal study involved a 9-week-successive administration of Trp-His at a dose of 0, 10 or 100 mg/kg per d. After 9-week administration, en face analyses provided the first direct evidence that the atherosclerotic lesion area was significantly reduced by 27 and 38 % for Trp-His dosed at 10 and 100 mg/kg per d, respectively, compared with the control group. Administration of Trp-His did not affect growth parameters such as body weight and feeding efficiency (P>0.1). Total serum cholesterol and HDL-cholesterol as well as lipid profiles in the liver did not differ between the tested groups. Taken together, the anti-atherosclerotic effect of dipeptide Trp-His should be addressed into physiological functions of bioactive peptides, in which the dipeptide may elicit the power by alternative mechanism(s), not by the regulation of lipid metabolism.


Assuntos
Apolipoproteínas E/deficiência , Aterosclerose/prevenção & controle , Dipeptídeos/uso terapêutico , Vasodilatadores/uso terapêutico , Animais , Aterosclerose/sangue , Aterosclerose/patologia , Colesterol/sangue , HDL-Colesterol/sangue , Lipídeos/sangue , Lipídeos/fisiologia , Fígado/metabolismo , Masculino , Camundongos , Camundongos Knockout , Oligopeptídeos/uso terapêutico , Seio Aórtico/patologia
2.
Biosci Biotechnol Biochem ; 73(6): 1314-7, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19502728

RESUMO

Pine bark extract (PBE) mainly contains proanthocyanidin in oligomers. It has many physiological effects, including antioxidant, anti-inflammatory, and so on. In this study, we investigated whether PBE has an anti-atherogenic effect on apoE-deficient mice. Male and female mice were fed a diet based on an AIN-76 formula (control diet), and that diet supplemented with 2% PBE (the PBF diet). The PBE diet, compared with the control diet, resulted in lowering the body weight gain and the adipose tissue weight in both male and female mice. The lesion area of the valve and the levels of serum and liver cholesterol in the male mice decreased on the PBE diet. The PBE diet had no significant effect on the levels of urinary isoprostanes or serum thiobarbituric acid reactive substances. These results indicate that dietary PBE can have beneficial effects on atherosclerosis development in male apoE-deficient mice by lowering the serum cholesterol level.


Assuntos
Apolipoproteínas E/fisiologia , Aterosclerose/prevenção & controle , Colesterol/sangue , Pinus/química , Casca de Planta/química , Extratos Vegetais/farmacologia , Animais , Apolipoproteínas E/genética , Feminino , Masculino , Camundongos , Camundongos Knockout
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...